Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (37)
Min Chen, Linxuan Cai, Yu Xiang, Ling Zhong & Jianyou Shi. (2023) Advances in non-radioactive PSMA-targeted small molecule-drug conjugates in the treatment of prostate cancer. Bioorganic Chemistry 141, pages 106889.
Crossref
Crossref
Benjamin P. M. Lake & Anthony F. Rullo. (2023) Offsetting Low-Affinity Carbohydrate Binding with Covalency to Engage Sugar-Specific Proteins for Tumor-Immune Proximity Induction. ACS Central Science 9:11, pages 2064-2075.
Crossref
Crossref
O.-F. Couturier, O. Medhioub, M. Bourgeois & F. Lacoeuille. (2023) L’antigène membranaire spécifique de la prostate (PSMA) et ses ligands radiomarqués pour la médecine nucléaire. Médecine Nucléaire 47:5, pages 241-246.
Crossref
Crossref
Lutfi A. Hasnowo, Maria S. Larkina, Evgenii Plotnikov, Vitalina Bodenko, Feruza Yuldasheva, Elena Stasyuk, Stanislav A. Petrov, Nikolai Y. Zyk, Aleksei E. Machulkin, Nikolai I. Vorozhtsov, Elena K. Beloglazkina, Valentine G. Nenajdenko, Vladimir Tolmachev, Anna Orlova, Alexander G. Majouga & Mekhman S. Yusubov. (2023) Synthesis, 123I-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-Based PSMA Inhibitors with a Tributylstannyl Prosthetic Group in Their Structures. International Journal of Molecular Sciences 24:15, pages 12206.
Crossref
Crossref
Olga O. Krasnovskaya, Daniil Abramchuck, Alexander Erofeev, Peter Gorelkin, Alexander Kuznetsov, Andrey Shemukhin & Elena K. Beloglazkina. (2023) Recent Advances in 64Cu/67Cu-Based Radiopharmaceuticals. International Journal of Molecular Sciences 24:11, pages 9154.
Crossref
Crossref
Niranjan Meher, Gary W. Ashley, Anil P. Bidkar, Suchi Dhrona, Cyril Fong, Shaun D. Fontaine, Denis R. Beckford Vera, David M. Wilson, Youngho Seo, Daniel V. Santi, Henry F. VanBrocklin & Robert R. Flavell. (2022) Prostate-Specific Membrane Antigen Targeted Deep Tumor Penetration of Polymer Nanocarriers. ACS Applied Materials & Interfaces 14:45, pages 50569-50582.
Crossref
Crossref
Daniela Imperio, Ambra A. Grolla, Marianna Moro, Valeria Bortolotto, Erika Del Grosso, Armando A. Genazzani & Luigi Panza. (2022) Functionalization of β-cyclodextrin with a urea-based PSMA ligand and preliminary studies on targeting prostate cancer cells. Bioorganic & Medicinal Chemistry Letters 73, pages 128890.
Crossref
Crossref
Regina Paula Soares Diego, Gandhi Rádis-Baptista, Ricardo Vale Albino Oliveira Filho, Estelita Tinoco Branco de Albuquerque, José Daniel Vieira de Castro, Katyane Moreira dos Santos, Joelan Ângelo de Lucena Santos, Guilherme Freire da Silveira Oliveira & Poliane Ângelo de Lucena Santos. (2022) Application of 68Ga-PSMA-11 PET/CT in the Diagnosis of Prostate Cancer Clinical Relapse. Current Radiopharmaceuticals 15:3, pages 228-235.
Crossref
Crossref
Nikolai Y. Zyk, Anton P. Ber, Ekaterina A. Nimenko, Radik R. Shafikov, Sergei A. Evteev, Stanislav A. Petrov, Anastasia A. Uspenskaya, Natalia S. Dashkova, Yan A. Ivanenkov, Dmitry A. Skvortsov, Elena K. Beloglazkina, Alexander G. Majouga & Aleksei E. Machulkin. (2022) Synthesis and initial in vitro evaluation of PSMA-targeting ligands with a modified aromatic moiety at the lysine ε-nitrogen atom. Bioorganic & Medicinal Chemistry Letters 71, pages 128840.
Crossref
Crossref
Hong Song, Kip E. Guja & Andrei Iagaru. (2022) PSMA theragnostics for metastatic castration resistant prostate cancer. Translational Oncology 22, pages 101438.
Crossref
Crossref
Harrison M. McCann, Benjamin P.M. Lake, Kyle S. Hoffman, Maria E. Davola, Karen L. Mossman & Anthony F. Rullo. (2022) Covalent Immune Proximity-Induction Strategy Using SuFEx-Engineered Bifunctional Viral Peptides. ACS Chemical Biology 17:5, pages 1269-1281.
Crossref
Crossref
Amel Sassi, Randa Mudathir & Angela Zeimingui. (2022) Novel Techniques for Small Molecule-Based Drug Delivery in Cancerous Tissue: A Literature Review. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal 6:4, pages 1-9.
Crossref
Crossref
Zahra Nikfarjam, Farshid Zargari, Alireza Nowroozi & Omid Bavi. (2022) Metamorphosis of prostate specific membrane antigen (PSMA) inhibitors. Biophysical Reviews 14:1, pages 303-315.
Crossref
Crossref
Martin K. Bakht, John J. Hayward, Farsheed Shahbazi-Raz, Magdalena Skubal, Ryo Tamura, Keith F. Stringer, Daniel Meister, Varadha Balaji Venkadakrishnan, Hui Xue, Adam Pillon, Mathew Stover, Adam Tronchin, Bre-Anne Fifield, Lavleen Mader, Sheng-Yu Ku, Gi Jeong Cheon, Keon Wook Kang, Yuzhuo Wang, Xuesen Dong, Himisha Beltran, Jan Grimm, Lisa A. Porter & John F. Trant. (2022) Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells. Proceedings of the National Academy of Sciences 119:4.
Crossref
Crossref
Stanislav A. Petrov, Nikolay Y. Zyk, Aleksei E. Machulkin, Elena K. Beloglazkina & Alexander G. Majouga. (2021) PSMA-targeted low-molecular double conjugates for diagnostics and therapy. European Journal of Medicinal Chemistry 225, pages 113752.
Crossref
Crossref
Niranjan Meher, Kyounghee Seo, Sinan Wang, Anil P. Bidkar, Miko Fogarty, Suchi Dhrona, Xiao Huang, Ryan Tang, Charles Blaha, Michael J. Evans, David R. Raleigh, Young-Wook Jun, Henry F. VanBrocklin, Tejal A. Desai, David M. Wilson, Tomoko Ozawa & Robert R. Flavell. (2021) Synthesis and Preliminary Biological Assessment of Carborane-Loaded Theranostic Nanoparticles to Target Prostate-Specific Membrane Antigen. ACS Applied Materials & Interfaces 13:46, pages 54739-54752.
Crossref
Crossref
Andrew Siow, Renata Kowalczyk, Margaret A. Brimble & Paul W.R. Harris. (2021) Evolution of Peptide-Based Prostate-Specific Membrane Antigen (PSMA) Inhibitors: An Approach to Novel Prostate Cancer Therapeutics. Current Medicinal Chemistry 28:19, pages 3713-3752.
Crossref
Crossref
Eden Kapcan, Benjamin Lake, Zi Yang, Ali Zhang, Matthew S. Miller & Anthony F. Rullo. (2021) Covalent Stabilization of Antibody Recruitment Enhances Immune Recognition of Cancer Targets. Biochemistry 60:19, pages 1447-1458.
Crossref
Crossref
Stanislav A. Petrov, Aleksei E. Machulkin, Anastasia A. Uspenskaya, Nikolay Y. Zyk, Ekaterina A. Nimenko, Anastasia S. Garanina, Rostislav A. Petrov, Vladimir I. Polshakov, Yuri K. Grishin, Vitaly A. Roznyatovsky, Nikolay V. Zyk, Alexander G. Majouga & Elena K. Beloglazkina. (2020) Polypeptide-Based Molecular Platform and Its Docetaxel/Sulfo-Cy5-Containing Conjugate for Targeted Delivery to Prostate Specific Membrane Antigen. Molecules 25:24, pages 5784.
Crossref
Crossref
Anastasiya A. Uspenskaya, Alexey E. Machulkin, Ekaterina A. Nimenko, Radik R. Shafikov, Stanislav A. Petrov, Dmitry A. Skvortsov, Elena K. Beloglazkina & Alexander G. Majouga. (2020) Influence of the dipeptide linker configuration on the activity of PSMA ligands. Mendeleev Communications 30:6, pages 756-759.
Crossref
Crossref
Colin T. Huang, Xin Guo, Cyril Bařinka, Shawn E. Lupold, Martin G. Pomper, Kathleen Gabrielson, Venu Raman, Dmitri Artemov & Sudath Hapuarachchige. (2020) Development of 5D3-DM1: A Novel Anti-Prostate-Specific Membrane Antigen Antibody-Drug Conjugate for PSMA-Positive Prostate Cancer Therapy. Molecular Pharmaceutics 17:9, pages 3392-3402.
Crossref
Crossref
Quan Liu, Lu Zhang, Xiuru Ji, Meong Cheol Shin, Shuping Xie, Baoyan Pan, Fei Yu, Jingwen Zhao & Victor C. Yang. (2020) A self-assembly and stimuli-responsive fusion gelonin delivery system for tumor treatment. Journal of Industrial and Engineering Chemistry 89, pages 409-415.
Crossref
Crossref
Maryam Afsharzadeh, Maryam Hashemi, Maryam Babaei, Khalil Abnous & Mohammad Ramezani. (2019) PEG‐PLA nanoparticles decorated with small‐molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells. Journal of Cellular Physiology 235:5, pages 4618-4630.
Crossref
Crossref
Kyul Kim, Hongmok Kwon, Cyril Barinka, Lucia Motlova, SangJin Nam, Doyoung Choi, Hyunsoo Ha, Hwanhee Nam, Sang-Hyun Son, Il Minn, Martin G. Pomper, Xing Yang, Zsofia Kutil & Youngjoo Byun. (2020) Novel β- and γ-Amino Acid-Derived Inhibitors of Prostate-Specific Membrane Antigen. Journal of Medicinal Chemistry 63:6, pages 3261-3273.
Crossref
Crossref
Xinyue Yao, Zhihao Zha, Karl Ploessl, Seok Rye Choi, Ruiyue Zhao, David Alexoff, Lin Zhu & Hank F. Kung. (2020) Synthesis and evaluation of novel radioiodinated PSMA targeting ligands for potential radiotherapy of prostate cancer. Bioorganic & Medicinal Chemistry 28:5, pages 115319.
Crossref
Crossref
Sang-Hyun Son, Hongmok Kwon, Hye-Hyun Ahn, Hwanhee Nam, Kyul Kim, SangJin Nam, Doyoung Choi, Hyunsoo Ha, Il Minn & Youngjoo Byun. (2020) Design and synthesis of a novel BODIPY-labeled PSMA inhibitor. Bioorganic & Medicinal Chemistry Letters 30:3, pages 126894.
Crossref
Crossref
Nasim Vahidfar, Maryam Fallahpoor, Saeed Farzanehfar, Ghasemali Divband & Hojjat Ahmadzadehfar. (2019) Historical review of pharmacological development and dosimetry of PSMA-based theranostics for prostate cancer. Journal of Radioanalytical and Nuclear Chemistry 322:2, pages 237-248.
Crossref
Crossref
Sagnik Sengupta, Mena Asha Krishnan, Amit Pandit, Premansh Dudhe, Rajesh Sharma & Venkatesh Chelvam. (2019) Tyrosine-based asymmetric urea ligand for prostate carcinoma: Tuning biological efficacy through in silico studies. Bioorganic Chemistry 91, pages 103154.
Crossref
Crossref
Hongmok Kwon, Sang‐Hyun Son & Youngjoo Byun. (2019) Prostate‐Specific Membrane Antigen (PSMA)‐Targeted Radionuclide Probes for Imaging and Therapy of Prostate Cancer. Asian Journal of Organic Chemistry 8:9, pages 1588-1600.
Crossref
Crossref
Alexey E. Machulkin, Dmitry A. Skvortsov, Yan A. Ivanenkov, Anton P. Ber, Mikhail V. Kavalchuk, Anastasia V. Aladinskaya, Anastasia A. Uspenskaya, Radik R. Shafikov, Ekaterina A. Plotnikova, Raisa I. Yakubovskaya, Ekaterina A. Nimenko, Nikolay U. Zyk, Elena K. Beloglazkina, Nikolay V. Zyk, Victor E Koteliansky & Alexander G. Majouga. (2019) Synthesis and biological evaluation of PSMA-targeting paclitaxel conjugates. Bioorganic & Medicinal Chemistry Letters 29:16, pages 2229-2235.
Crossref
Crossref
A. A. Uspenskaya, A. É. Machulkin, A. G. Mazhuga & E. K. Beloglazkina. (2019) Conjugates of Prostate-Specific Membrane Antigen Ligands with Antitumor Drugs. Pharmaceutical Chemistry Journal 53:4, pages 288-297.
Crossref
Crossref
Nikita V. Suvorov, Alexey E. Machulkin, Anna V. Ivanova, Alexander M. Popkov, Elizaveta A. Bondareva, Ekaterina A. Plotnikova, Raisa I. Yakubovskaya, Alexander G. Majouga, Andrey F. Mironov & Mikhail A. Grin. (2018)
Synthesis of PSMA-targeted 13
1
- and 15
2
-substituted chlorin e
6
derivatives and their biological properties
. Journal of Porphyrins and Phthalocyanines 22:11, pages 1030-1038.
Crossref
Crossref
Maria V. Efremova, Victor A. Naumenko, Marina Spasova, Anastasiia S. Garanina, Maxim A. Abakumov, Anastasia D. Blokhina, Pavel A. Melnikov, Alexandra O. Prelovskaya, Markus Heidelmann, Zi-An Li, Zheng Ma, Igor V. Shchetinin, Yuri I. Golovin, Igor I. Kireev, Alexander G. Savchenko, Vladimir P. Chekhonin, Natalia L. Klyachko, Michael Farle, Alexander G. Majouga & Ulf Wiedwald. (2018) Magnetite-Gold nanohybrids as ideal all-in-one platforms for theranostics. Scientific Reports 8:1.
Crossref
Crossref
Zhantong Wang, Orit Jacobson, Rui Tian, Ronnie C. Mease, Dale O. Kiesewetter, Gang Niu, Martin G. Pomper & Xiaoyuan Chen. (2018)
Radioligand Therapy of Prostate Cancer with a Long-Lasting Prostate-Specific Membrane Antigen Targeting Agent
90
Y-DOTA-EB-MCG
. Bioconjugate Chemistry 29:7, pages 2309-2315.
Crossref
Crossref
Susanne Lütje, Roger Slavik, Wolfgang Fendler, Ken Herrmann & Matthias Eiber. (2017) PSMA ligands in prostate cancer – Probe optimization and theranostic applications. Methods 130, pages 42-50.
Crossref
Crossref
Chunlan Liu, Shu Lu, Limin Yang, Peijie Chen, Peiming Bai & Qiuquan Wang. (2017) Near-Infrared Neodymium Tag for Quantifying Targeted Biomarker and Counting Its Host Circulating Tumor Cells. Analytical Chemistry 89:17, pages 9239-9246.
Crossref
Crossref
Steven P. Rowe, Alexander Drzezga, Bernd Neumaier, Markus Dietlein, Michael A. Gorin, Michael R. Zalutsky & Martin G. Pomper. (2016) Prostate-Specific Membrane Antigen–Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer. Journal of Nuclear Medicine 57:Supplement 3, pages 90S-96S.
Crossref
Crossref